miracor medical s picso system receives ce mark -

Miracor Medical Raises 24M€

The PiCSO Impulse System has received 'Breakthrough Designation' from the FDA in 2019 and the CE-Mark in June 2020 "We are very happy to welcome strong new investors and to receive the continued endorsement and belief in Miracor from our existing shareholders

Miracor Medical's PiCSO System receives CE mark

Picso system Miracor Medical has announced the award of the CE mark for its latest generation of PiCSO Impulse Catheter and PiCSO Impulse Console which is indicated for the treatment of anterior STEMI patients It says the new system features

Miracor Medical raises 24M€

The PiCSO Impulse System has received 'Breakthrough Designation' from the FDA in 2019 and the CE-Mark in June 2020 "We are very happy to welcome strong new investors and to receive the continued endorsement and belief in Miracor from our existing shareholders Following the recent CE Mark we have hired a very experienced commercial

Miracor Medical Raises 24M€

The PiCSO Impulse System has received 'Breakthrough Designation' from the FDA in 2019 and the CE-Mark in June 2020 "We are very happy to welcome strong new investors and to receive the continued endorsement and belief in Miracor from our existing shareholders

Miracor Medical Raises 24M?

The PiCSO Impulse System has received ?Breakthrough Designation' from the FDA in 2019 and the CE-Mark in June 2020 We are very happy to welcome strong new investors and to receive the continued endorsement and belief in Miracor from our existing shareholders

Het PiCSO

Jun 23 2020Miracor Medical's PiCSO System Receives CE Mark AWANS Belgium–(BUSINESS WIRE)– Miracor Medical SA (Miracor Medical) has announced the award of the CE Mark for its latest generation of PiCSO Impulse Catheter and PiCSO Impulse Console which is indicated for the treatment of anterior STEMI patients

Miracor Medical's PiCSO Impulse System Earns CE Mark

Miracor Medical has earned a CE mark certification for the latest version of its PiCSO Impulse catheter and console The system uses a catheter and balloon in conjunction with a patient monitor to treat anterior ST-elevation myocardial infarction (STEMI) a serious form of heart attack that involves blockage of a major artery The CE mark was supported by data from two clinical trials that

Miracor Medical's PiCSO System Receives CE Mark

Miracor Medical's PiCSO System Receives CE Mark Editorial Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News information Analysis Opinion Press Releases Reviews Research reports covering various economies industries products services and companies

Heart diseases

Miracor Medical's PiCSO System receives CE mark Ngy 25/06/2020 | 09:19 Miracor Medical has announced the award of the CE mark for its latest generation of PiCSO Impulse Catheter and PiCSO Impulse Console which is indicated for the treatment of anterior STEMI patients It says the new system features improvements in ease of use

Miracor Medical's PiCSO System Receives CE Mark

Jun 24 2020Miracor Medical's PiCSO System Receives CE Mark June 24 2020 June 24 2020 G-MedTech 0 Comments Miracor Medical SA has announced the award of the CE Mark for its latest generation of PiCSO Impulse Catheter and PiCSO Impulse Console which is indicated for the treatment of anterior STEMI patients

Miracor Medical's PiCSO System receives CE Mark

Jun 23 2020Miracor Medical's PiCSO System receives CE Mark Awans Belgium June 23 2020 - Miracor Medical SA (Miracor Medical) has announced the award of the CE Mark for its latest generation of PiCSO Impulse Catheter and PiCSO Impulse Console which is indicated for the treatment of anterior STEMI patients

Miracor Medical's PiCSO System Receives CE Mark

Miracor Medical SA (Miracor Medical) has announced the award of the CE Mark for its latest generation of PiCSO Impulse Catheter and PiCSO Impulse Console which is indicated for the treatment of anterior STEMI patients The new system features improvements in ease of use PiCSO therapy is delivered by interventional cardiologists during the primary PCI (Percutaneous Coronary Intervention

Venture Capital Access Online

The PiCSO Impulse System has received 'Breakthrough Designation' from the FDA in 2019 and the CE-Mark in June 2020 "We are very happy to welcome strong new investors and to receive the continued endorsement and belief in Miracor from our existing shareholders

Venture Capital Access Online

The PiCSO Impulse System has received 'Breakthrough Designation' from the FDA in 2019 and the CE-Mark in June 2020 "We are very happy to welcome strong new investors and to receive the continued endorsement and belief in Miracor from our existing shareholders

Portfolio News

Miracor Medical's PiCSO System receives CE Mark Miracor Medical SA (Miracor Medical) has announced the award of the CE Mark for its latest generation of PiCSO Impulse Catheter and PiCSO Impulse Console which is indicated for the treatment of anterior STEMI patients The new system features improvements in ease of use

Miracor Medical Raises 24M€

The PiCSO Impulse System has received 'Breakthrough Designation' from the FDA in 2019 and the CE-Mark in June 2020 We are very happy to welcome strong new investors and to receive the continued endorsement and belief in Miracor from our existing shareholders

Miracor Medical Raises 24M€

The PiCSO Impulse System has received 'Breakthrough Designation' from the FDA in 2019 and the CE-Mark in June 2020 "We are very happy to welcome strong new investors and to receive the continued endorsement and belief in Miracor from our existing shareholders

Miracor Medical Begins Enrollment in PiCSO

Jul 29 2019July 25 2019—Miracor Medical SA announced the initiation and first patient enrollment in the PiCSO-AMI-I study to evaluate the benefits of pressure-controlled intermittent coronary sinus occlusion (PiCSO) therapy compared with conventional percutaneous coronary intervention (PCI) for the treatment of anterior ST-segment elevation myocardial infarction (STEMI) patients

Miracor Medical's PiCSO System receives CE mark

Picso system Miracor Medical has announced the award of the CE mark for its latest generation of PiCSO Impulse Catheter and PiCSO Impulse Console which is indicated for the treatment of anterior STEMI patients It says the new system features

Miracor receives CE mark for the PICSO Impulse System

Miracor Medical Systems announced on 16 December 2010 that the company has received the CE mark for the PICSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System designed to improve acute coronary syndrome revascularisation following primary percutaneous coronary intervention (PCI)

Miracor's PICSO System is used for the first time under

VIENNA Austria—Miracor Medical Systems announced today that its PICSO System was used for the first time under CE mark in the UK to treat a patient with a large acute heart attack (STEMI) Interventional cardiologist Dr Magdi El-Omar performed the PICSO procedure at Manchester Royal Infirmary (Manchester England)

Miracor receives CE mark for the PICSO Impulse System

Miracor Medical Systems announced on 16 December 2010 that the company has received the CE mark for the PICSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System designed to improve acute coronary syndrome revascularisation following primary percutaneous coronary intervention (PCI)

Miracor Medical's PiCSO System Receives CE Mark

Jun 23 2020Miracor Medical's PiCSO System Receives CE Mark Miracor Medical SA (Miracor Medical) has announced the award of the CE Mark for its latest generation of PiCSO Impulse Catheter and PiCSO Impulse Console which is indicated for the treatment of anterior STEMI patients The new system features improvements in ease of use

Europe Archives

Aug 11 2020Philips and University Medical Center Utrecht partner to advance quantitative MR with MR-STAT at ISMRM 2020 August 11 2020 August 11 2020 G-MedTech 0 Comments Partnerships Philips The exclusive multi-year research partnership will establish a global clinical research network with the aim of fully commercializing the technology which has

Miracor Medical's PiCSO System Receives CE Mark

Miracor Medical SA (Miracor Medical) has announced the award of the CE Mark for its latest generation of PiCSO Impulse Catheter and PiCSO Impulse Console which is indicated for the treatment of anterior STEMI patients The new system features improvements in ease of use PiCSO therapy is delivered by interventional cardiologists during the primary PCI (Percutaneous Coronary Intervention

Medical Devices

Jun 25 2020Preceptis' Ear Tube System Receives FDA Clearance Akili Grabs CE Mark for Children's Digital ADHD Treatment June 24 2020 The FDA last week cleared EndeavorRx for marketing in the U S Read More Miracor Medical's PiCSO Impulse System Earns CE Mark June 24 2020 The company said the latest version of the system features

Miracor Medical's PiCSO Impulse System Earns CE Mark

Miracor Medical has earned a CE mark certification for the latest version of its PiCSO Impulse catheter and console The system uses a catheter and balloon in conjunction with a patient monitor to treat anterior ST-elevation myocardial infarction (STEMI) a serious form of heart attack that involves blockage of a major artery The CE mark was supported by data from two clinical trials that

Miracor Medical raises €24m Series E funding to advance

Sep 04 2020The PiCSO Impulse System has received 'Breakthrough Designation' from the FDA in 2019 and the CE-Mark in June 2020 Miracor is currently recruiting patients in a landmark European randomized controlled trial PiCSO-AMI-I to further demonstrate the benefits of PiCSO therapy as compared with conventional PCI for the treatment of anterior

Miracor Medical's PiCSO System Receives CE Mark

Jun 23 2020Miracor Medical's PiCSO System Receives CE Mark Miracor Medical SA (Miracor Medical) has announced the award of the CE Mark for its latest generation of PiCSO Impulse Catheter and PiCSO Impulse Console which is indicated for the treatment of anterior STEMI patients The new system features improvements in ease of use

Miracor Medical Raises 24M€ – Latino News

Funds will be used for clinical studies and initiation of commercialization AWANS Belgium--(BUSINESS WIRE)--Miracor Medical SA (Miracor Medical) has announced the closing of a 24M€ Series-E round of financing The round was led by a new corporate strategic investor joined by co-investor Yonghua Current investors Earlybird Noshaq Quest for Growth SFPI-FPIM SRIW and another corporate

FDA Breakthrough Device Designation for the PiCSO impulse

Miracor Medical has been granted Breakthrough Device Designation by the FDA for its PiCSO Impulse System for treatment of ST-segment elevation myocardial infarction (STEMI) patients The PiCSO impulse system is designed to clear the coronary microcirculation by intermittently occluding

Online customer service

Welcome ! If you have any questions or suggestions about our products and services,please feel free to tell us anytime!